Heart Disease News and Research

Latest Heart Disease News and Research

Link between CTNNA3 gene mutations and arrhythmogenic right ventricular cardiomyopathy

Unfortunately, newspaper articles about young athletes dying suddenly on the field are not unheard of. Such reports fuel discussions about compulsory screening, for example of young footballers, for heart failure. Research by scientists from Ghent (VIB/UGent) and Italy will benefit these screening methods.

12 Dec 2012

Examining Americans' health: Longer, but sicker, lives; Childhood obesity drops

A new report finds Americans may be living longer thanks to medical advances, but they may also be sicker. Meanwhile, childhood obesity may be dropping in several cities around the nation.

12 Dec 2012

Researchers decipher mechanism by which anophelin binds to thrombin

An international project lead by the Molecular and Cell Biology Institute of Porto University with the participation of researchers from IMIM (Hospital del Mar Medical Research Institute) has, for the first time ever, deciphered the mechanism by which a substance called anophelin binds to an enzyme (thrombin) involved in the process of blood coagulation.

12 Dec 2012

Kaiser Permanente grant to help Children's Oakland rebuild and modernize 100-year-old hospital

Children's Hospital & Research Center Oakland announced today a $5 million grant from Kaiser Permanente to benefit the 100-year-old, not-for-profit medical center's rebuild and modernization efforts. This contribution will make a profound impact in the community and the quality of care available to all children.

12 Dec 2012

Tiotropium benefits patients with chronic obstructive pulmonary disease

In order to widen the narrowed airways in patients with chronic obstructive pulmonary disease (COPD), tiotropium bromide (tiotropium in brief) is one of the drugs available that can be prescribed for inhalation. The German Institute for Quality and Efficiency in Health Care (IQWiG) has examined whether tiotropium offers a perceptible advantage to patients compared to a dummy medication (placebo) and to other COPD drugs.

12 Dec 2012

Gestational age and size at birth affect risk of early diagnosis of esophagitis

Infants that are born preterm or with impaired growth have an increased risk of developing gastroesophageal reflux disease (GERD), possibly leaving them vulnerable to the development of esophageal adenocarcinoma later in life.

12 Dec 2012

Astellas, FibroGen commence FG-4592/ASP1517 Phase 3 clinical program in CKD anemia

FibroGen, Inc., and Astellas Pharma Inc., announced today the initiation of the first clinical study in the Phase 3 clinical development program of FG-4592/ASP1517, an orally administered small molecule, for treatment of anemia associated with chronic kidney disease ("CKD") in patients not on dialysis and on dialysis, to support approval in the U.S. and Europe.

12 Dec 2012

Viewpoints: Sen. Portman's Rx for deficit talks; Gerson says Obama needs to give Boehner political cover to make a deal

Washington needs to pursue structural reforms in the country's important but unsustainable entitlement programs and in an inefficient, outdated tax code. By doing so, lawmakers can responsibly avoid the immediate cliff while addressing the long-term fiscal crisis and spurring job creation.

12 Dec 2012

Lenalidomide effective alternative in lupus

The thalidomide derivative, lenalidomide, is a “safe” and effective treatment in refractory cutaneous lupus erythematosus patients, although three-quarters of patients experience clinical relapse after the drug is withdrawn, say Spanish researchers.

11 Dec 2012

High-altitude treatment may help severe asthma patients

Individuals with severe refractory asthma may benefit from high-altitude treatment, irrespective of their sensitivity to airborne allergens, suggest findings from a study conducted in the Swiss Alps.

11 Dec 2012

Cognitive impairments linked to mood episode recurrence risk

Cognitive impairments are associated with an increased risk for mood episode recurrence in euthymic patients with bipolar disorder, researchers report.

11 Dec 2012

CYP2J2 implicated in preeclampsia

Study findings suggest that uteroplacental cytochrome P450 subfamily 2J polypeptide 2 overexpression contributes to preeclampsia.

11 Dec 2012

Telestroke networks benefit hospital bank balances

Telestroke networks can increase the number of patients successfully discharged home while saving money for all hospitals involved, show US study results.

11 Dec 2012

Depression treatment ‘should target emotional control’

Being able to regulate emotions is a key driver of patients’ improvement in symptoms when undergoing treatment for depression, German researchers have shown.

11 Dec 2012

Chest-compression-only CPR ‘should be standard’ for bystander resuscitation

Cardiopulmonary resuscitation with chest compressions only seems to be the most effective form of resuscitation when delivered by lay bystanders along with public-access automated external defibrillation, research suggests.

11 Dec 2012

Studies examine current treatment standards for patients with clotting disorders

Studies presented today at the 54th Annual Meeting of the American Society of Hematology (ASH) examine current treatment standards for patients with clotting disorders in an effort to improve outcomes.

11 Dec 2012

Cedars-Sinai first in Los Angeles County to achieve Comprehensive Stroke Center Certification

Cedars-Sinai is one of the first five medical centers in the nation and the first in Los Angeles County to achieve Comprehensive Stroke Center Certification from The Joint Commission and the American Heart Association/American Stroke Association.

11 Dec 2012

AMAG presents new data from two ferumoxytol phase III trials on IDA at ASH annual meeting

AMAG Pharmaceuticals, Inc. today announced that new data from two pivotal phase III clinical trials were presented at the American Society of Hematology's (ASH) annual meeting in Atlanta, Georgia.

11 Dec 2012

Merrimack announces results from MM-302 Phase I trial on advanced HER2 positive breast cancer

Merrimack Pharmaceuticals, Inc. today announced Phase I clinical trial results for MM-302, the company's novel agent for the treatment of advanced HER2 positive (HER2+ or ErbB2+) breast cancer.

11 Dec 2012

Alpha arrestins may play a role in cell signaling that is crucial to new drug development

A newly found understanding of receptor signaling may have revealed a better way to design drugs. A study from Nationwide Children's Hospital suggests that a newly identified group of proteins, alpha arrestins, may play a role in cell signaling that is crucial to new drug development.

11 Dec 2012

Heart Disease News and Research

Latest Heart Disease News and Research

Link between CTNNA3 gene mutations and arrhythmogenic right ventricular cardiomyopathy

Examining Americans' health: Longer, but sicker, lives; Childhood obesity drops

Researchers decipher mechanism by which anophelin binds to thrombin

Kaiser Permanente grant to help Children's Oakland rebuild and modernize 100-year-old hospital

Tiotropium benefits patients with chronic obstructive pulmonary disease

Gestational age and size at birth affect risk of early diagnosis of esophagitis

Astellas, FibroGen commence FG-4592/ASP1517 Phase 3 clinical program in CKD anemia

Viewpoints: Sen. Portman's Rx for deficit talks; Gerson says Obama needs to give Boehner political cover to make a deal

Lenalidomide effective alternative in lupus

High-altitude treatment may help severe asthma patients

Cognitive impairments linked to mood episode recurrence risk

CYP2J2 implicated in preeclampsia

Telestroke networks benefit hospital bank balances

Depression treatment ‘should target emotional control’

Chest-compression-only CPR ‘should be standard’ for bystander resuscitation

Studies examine current treatment standards for patients with clotting disorders

Cedars-Sinai first in Los Angeles County to achieve Comprehensive Stroke Center Certification

AMAG presents new data from two ferumoxytol phase III trials on IDA at ASH annual meeting

Merrimack announces results from MM-302 Phase I trial on advanced HER2 positive breast cancer

Alpha arrestins may play a role in cell signaling that is crucial to new drug development

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Heart Disease News and Research

Latest Heart Disease News and Research

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in